These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3926584)

  • 1. Effect of teleocidin on immune responses in vitro.
    Yamashita U
    Jpn J Cancer Res; 1985 Jun; 76(6):532-40. PubMed ID: 3926584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive activity of 12-O-tetradecanoyl phorbol-13-acetate on the induction of cytotoxic T cells in vitro.
    Yamashita U
    Jpn J Cancer Res; 1985 Jul; 76(7):618-25. PubMed ID: 3928558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor promoter teleocidin induces IL 2 receptor expression and IL 2-independent proliferation of human peripheral blood T cells.
    Isakov N; Bleackley RC; Shaw J; Altman A
    J Immunol; 1985 Oct; 135(4):2343-50. PubMed ID: 3928744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenic and comitogenic properties of the indole alkaloid class of tumor promotors.
    Novogrodsky A; Patya M; Fujiki H; Rubin AL; Stenzel KH
    J Cell Physiol; 1984 Jul; 120(1):36-40. PubMed ID: 6429160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Des-O-methylolivoretin C is a new member of the teleocidin class of tumor promoters.
    Ninomiya M; Fujiki H; Paik NS; Hakii H; Suganuma M; Hitotsuyanagi Y; Aimi N; Sakai S; Endo Y; Shudo K
    Jpn J Cancer Res; 1986 Mar; 77(3):222-5. PubMed ID: 3084411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of natural killing by tumor promoters: the regulatory influence of adherent cells varies with the type of target cell.
    Kabelitz D
    Immunobiology; 1985 May; 169(4):436-46. PubMed ID: 2408998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self recognition of accessory cell Ia determinants is required for the in vitro generation of hapten-specific cytotoxic T lymphocyte responses.
    Kruisbeek AM; Andrysiak PM; Singer A
    J Immunol; 1983 Oct; 131(4):1650-5. PubMed ID: 6604748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for cytostatic T cell activity in the effector mechanism against syngeneic TMT mammary tumor cells in mice.
    Kurata S; Tsuchiya T; Norimura T; Yamashita U
    J Immunol; 1983 Jan; 130(1):496-500. PubMed ID: 6600195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Ia-positive cells in induction of secondary human immune responses to haptens in vitro.
    Rich RR; Abramson SL; Seldin MF; Puck JM; Levy R
    J Exp Med; 1980 Aug; 152(2 Pt 2):218s-234s. PubMed ID: 6967938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic function of endothelial cells: guinea pig aortic endothelial cells support mitogen-induced T lymphocyte activation, but do not function as antigen-presenting cells.
    Roska AK; Johnson AR; Lipsky PE
    J Immunol; 1984 Jan; 132(1):136-45. PubMed ID: 6197441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of interleukin 2 dependent cytotoxic T cell line cells. Different protein kinase C activators achieve the same maximal promotion, but with distinct dose-response profiles.
    Gavériaux C; Loor F
    Int Arch Allergy Appl Immunol; 1989; 88(3):294-6. PubMed ID: 2785967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the murine autologous mixed lymphocyte reaction. I. Characterization of the stimulator cells and their recognition sites].
    Ishida Y
    Hokkaido Igaku Zasshi; 1982 Sep; 57(5):614-23. PubMed ID: 6983996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses.
    Golding H; Singer A
    J Immunol; 1984 Aug; 133(2):597-605. PubMed ID: 6203969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
    Louis JA; Moedder E; MacDonald HR; Engers HD
    J Immunol; 1981 May; 126(5):1661-6. PubMed ID: 6452473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.